Author:
de Vries Rory D.,Schmitz Katharina S.,Bovier Francesca T.,Noack Danny,Haagmans Bart L.,Biswas Sudipta,Rockx Barry,Gellman Samuel H.,Alabi Christopher A.,de Swart Rik L.,Moscona Anne,Porotto Matteo
Abstract
AbstractContainment of the COVID-19 pandemic requires reducing viral transmission. SARS-CoV-2 infection is initiated by membrane fusion between the viral and host cell membranes, mediated by the viral spike protein. We have designed a dimeric lipopeptide fusion inhibitor that blocks this critical first step of infection for emerging coronaviruses and document that it completely prevents SARS-CoV-2 infection in ferrets. Daily intranasal administration to ferrets completely prevented SARS-CoV-2 direct-contact transmission during 24-hour co-housing with infected animals, under stringent conditions that resulted in infection of 100% of untreated animals. These lipopeptides are highly stable and non-toxic and thus readily translate into a safe and effective intranasal prophylactic approach to reduce transmission of SARS-CoV-2.One-sentence summaryA dimeric form of a SARS-CoV-2-derived lipopeptide is a potent inhibitor of fusion and infection in vitro and transmission in vivo.
Publisher
Cold Spring Harbor Laboratory
Reference52 articles.
1. Structure, Function, and Evolution of Coronavirus Spike Proteins;Annu Rev Virol,2016
2. M. Hoffmann et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, (2020).
3. Y. Wan , J. Shang , R. Graham , R. S. Baric , F. Li , Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol 94, (2020).
4. P. Zhou et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, (2020).
5. The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献